Iron dysregulation in beta-thalassemia

Area of Science:

• Hematology
• Molecular Biology
• Physiology

Background:

• Iron homeostasis is crucial, with over one billion people affected by iron deficiency anemia and overload.
• The hepcidin-ferroportin axis is the primary regulator of cellular iron balance in humans.
• Dysregulation of iron homeostasis leads to organ deposition and is a major cause of mortality in beta-thalassemia.

Approach:

• This review focuses on factors mediating hepcidin-related iron dysregulation in beta-thalassemia.
• It examines the transcriptional, post-transcriptional, and post-translational regulation of ferroportin.
• The role of hepcidin in the post-translational regulation of ferroportin via endocytosis and lysosomal degradation is discussed.

Key Points:

• Beta-thalassemia is characterized by suppressed hepcidin, ineffective erythropoiesis, anemia, and iron overload.
• Hepcidin, a liver hormone, binds to ferroportin, the sole iron exporter, triggering its degradation.
• Understanding these mechanisms is key to developing new treatments for iron overload.

Conclusions:

• Hepcidin-ferroportin axis dysregulation is central to iron overload in beta-thalassemia.
• Targeting factors that mediate hepcidin regulation offers potential therapeutic avenues.
• Improved understanding may enhance long-term prognosis for beta-thalassemia patients.